Susan E. Krown
Impact in
Papers in
- Co-authors
- Craig E. MetrokaHerbert F. OettgenFrancisco X. RealJ WernzPaul B. ChapmanMarcia A. TestaEthel CesarmanJeannette Y. Lee
- Journals
- Journal of Clinical Oncology (19 papers)Cancer (12 papers)JAIDS Journal of Acquired Immune Deficiency Syndromes (10 papers)Current Opinion in Oncology (4 papers)Hematology/Oncology Clinics of North America (4 papers)
- Partner nations
- United StatesZimbabweSouth Africa
In The Last Decade
Susan E. Krown
125 papers receiving 5.9k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Oncology 3.7k
- Virology 480
- Pathology and Forensic Medicine 1.5k
- Immunology 1.3k
- Genetics 548
Countries citing papers authored by Susan E. Krown
This map shows the geographic impact of Susan E. Krown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan E. Krown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan E. Krown more than expected).
Fields of papers citing papers by Susan E. Krown
This network shows the impact of papers produced by Susan E. Krown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan E. Krown. The network helps show where Susan E. Krown may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Susan E. Krown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 1 | |
| 2 | 2015 | 9 | |
| 3 | 2011 | 28 | |
| 4 | 2010 | 47 | |
| 5 | 2010 | 109 | |
| 6 | 2009 | 16 | |
| 7 | 2008 | 146 | |
| 8 | 2008 | 10 | |
| 9 | 2006 | 38 | |
| 10 | 2006 | 25 | |
| 11 | 2002 | 42 | |
| 12 | 1999 | 11 | |
| 13 | 1992 | 61 | |
| 14 | 1992 | 7 | |
| 15 | 1990 | 5 | |
| 16 | 1989 | 339 | |
| 17 | Phenotypic changes induced by recombinant interferon-gamma (r-IFN-γ) therapy in a case of chronic lymphocytic leukemia (CLL): Correlation with in vitro induction | 1985 | 1 |
| 18 | American cancer society Phase I trial of naturally produced beta-interferon. | 1984 | 21 |
| 19 | 1983 | 10 | |
| 20 | Phase I study of intraventricularly administered human α interferon in patients with leptomeningeal tumor | 1983 | 3 |
About Susan E. Krown
Susan E. Krown is a scholar working on Oncology, Virology, Pathology and Forensic Medicine, Hematology and Immunology, having authored 129 papers that have together received 6.2k indexed citations. Recurring topics across this work include Viral-associated cancers and disorders (68 papers), Lymphoma Diagnosis and Treatment (46 papers), HIV Research and Treatment (15 papers), HIV/AIDS drug development and treatment (14 papers), Chronic Lymphocytic Leukemia Research (13 papers), Histiocytic Disorders and Treatments (12 papers), Immune Cell Function and Interaction (12 papers) and Immunotherapy and Immune Responses (10 papers). The work is most often cited by research in Oncology (3.7k citations), Virology (480 citations), Pathology and Forensic Medicine (1.5k citations), Immunology (1.3k citations) and Genetics (548 citations). Susan E. Krown has collaborated with scholars based in United States, Zimbabwe and South Africa. Frequent co-authors include Craig E. Metroka, Herbert F. Oettgen, Francisco X. Real, J Wernz, Paul B. Chapman, Marcia A. Testa, Ethel Cesarman, Jeannette Y. Lee, Jedd D. Wolchok and Jie Huang. Their work appears in journals such as Journal of Clinical Oncology, Cancer, JAIDS Journal of Acquired Immune Deficiency Syndromes, Current Opinion in Oncology and Hematology/Oncology Clinics of North America.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.